Hormonal treatment for prostate cancer

Area of Science:

• Oncology
• Endocrinology

Background:

• Androgen deprivation therapy (ADT) has been the standard for advanced prostate cancer for decades.
• While effective initially, most patients develop resistance, leading to progressive disease.
• ADT can cause significant side effects and is increasingly used earlier due to PSA testing.

Purpose of the Study:

• To explore alternative hormonal interventions for advanced prostate cancer.
• To identify strategies that minimize ADT use and its associated morbidities.
• To improve both anti-tumor efficacy and the side effect profile of prostate cancer treatment.

Main Methods:

• Review of current treatment paradigms for advanced prostate cancer.
• Analysis of the limitations and side effects of continuous androgen suppression.
• Exploration of emerging hormonal therapies as alternatives or adjuncts.

Main Results:

• Androgen deprivation therapy (ADT) is effective but leads to eventual resistance.
• ADT is associated with a range of adverse effects impacting patient quality of life.
• Early intervention with ADT for rising PSA levels necessitates long-term treatment exposure.

Conclusions:

• There is a critical need for novel therapeutic strategies in advanced prostate cancer.
• Alternative hormonal interventions hold promise for overcoming ADT resistance.
• Optimizing treatment aims to enhance efficacy while mitigating side effects and reducing healthcare costs.